Secondary cytoreductive surgery for recurrent ovarian cancer improves overall survival - BJMO
Shannon Westin on X: "This #ASCO20 was notable for two major trials exploring secondary cytoreductive surgery in recurrent #ovariancancer - DESKTOP III and SOC -1 #ASCO20 #SGOatASCO #gyncsm https://t.co/pHGWklYWKs" / X
AGO DESKTOP III/ENGOT-ov20: Impact of secondary cytoreductive surgery in recurrent ovarian cancer - ecancer
Minicorso di metodologia della ricerca clinica: I trial sui NAO insegnano – Prato,10 Ottobre 2023 – Executive Congress
Free 14-day trial of Parallels Desktop for Mac | Apple M1, M2, M-series compatible
SLA: nuove linee guida internazionali per i trial clinici | La Statale News
SellZone® Assembled Desktop Computer Core 2 Duo 3.0GHZ Processor, G31 Motherboard, 17 Inch LED Monitor, 4GB RAM, Windows 7 & Office Trial Version with Web Camera Mic Speaker (Hard Drive, 250GB) :
Diapositiva 1
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer | NEJM
First-in-human phase I trial to assess the ef | EurekAlert!
A trial looking at surgery for ovarian cancer that has come back (DESKTOP 3, ENGOT ov20) | Cancer Research UK
Biostatistics Software Downloadable or Online
IJGC on X: "#podcast: The DESKTOP III Trial with Philipp Harter This week, @pedroramirezMD is joined by Prof. Philipp Harter to discuss The DESKTOP III Trial. ♫https://t.co/CZQXdMT97W @_kem @IGCSociety @ESGO_society @OncoAlert @agz_eriksson #
Clinical Conundrums: Choosing the Best Management Approaches in Patients With Ovarian Cancer Thomas J. Herzog, MD Director, Division of Gynecologic Oncology. - ppt download
Ovarian Committee. Closed Trials Upfront Surgery vs Neoadjuvant Chemotherapy Patients closed / 550 Leading EORTC Participating NCIC CTG Presentation. - ppt download
GRIPHON Trial for Pulmonary Arterial Hypertension (PAH)
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer | NEJM
PPT - An Oncology Exchange Activity PowerPoint Presentation, free download - ID:5600388
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer | NEJM
Shannon Westin on X: "Patient selection clearly matters - DESKTOP III used the AGO criteria, SOC-1 used iMODEL score - both have been validated to predict ability to achieve complete resection -
Research Update on Ovarian Cancer | PPT
A trial looking at surgery for ovarian cancer that has come back (DESKTOP 3, ENGOT ov20) | Cancer Research UK
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer | NEJM
